Login

Paion advancing its general anesthesia drug candidate - Wolfgang Soehngen, CEO, Paion 00:00:00

Share On Facebook Share On Twitter

Paion advancing its general anesthesia drug candidate

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Why a Solid Budget is Essential for Effective Financial Planning
00:10:00
Invests in next-generation brands|Brian Spaly,General Partner,Brand Foundry Ventures
00:10:00
Outcrop Silver Hits High-Grade Silver with New Drill Results at Aguilar Project
00:10:00
Insights on Upstream Consolidation and Redetermination Trends from Keith Buchanan"
00:10:00
State Street Global Advisors Expands Reach to Dubai, Embracing Regional Growth | Yie-Hsin Hung, CEO , State Street Global Advisors.
00:10:00
Champion Iron Eyes Expansion in High-Grade Iron Ore for Decarbonizing Steel Industry | David Cataford, CEO , Champion Iron Ltd.
00:10:00
Building a Floral Empire: Jim McCann on Inclusion, Innovation, and Integrity | Jim McCann, Founder , 1-800-Flowers.com Inc.
00:10:00
Empowering Women in the Workplace: Career Insights from Anjie Peña Kallas and Abby Groom at T. Rowe Price
00:10:00
Strong Financial Performance and Strategic Vision: Santander's 2023 Achievements | Hector Grisi , CEO , Banco Santander.
00:10:00
Roscan Gold CEO Nana Sangmuah Discusses Drilling Successes and Strategic Partnerships at Candioli Project in Mali
00:10:00
Dr. Bret Weinstein shares insights on "The Diary Of A CEO" podcast, while Peter Kaufman discusses M&A strategies in his Gordian Group LLC interview on M&A TV.
00:10:00
How We Analyze a Company | Henrique Bredda - Alaska Investimentos,

© 2026 Nehu